Brief: Targovax Says Prioritize Resources On Unlocking The Potential Of Its Circrna Platform

Circio Holding ASA

07/03/2023 16:54

March 7 (Reuters) - Targovax ASA  TRVX.OL :
    * TARGOVAX TO PRIORITIZE RESOURCES ON UNLOCKING THE
POTENTIAL OF
ITS CIRCRNA PLATFORM
    * ONCOS-102 PHASE 2 DEVELOPMENT WILL ONLY PROCEED ONCE A
PARTNERSHIP OR ADDITIONAL FINANCING IS SECURED
    * SAYS OVERALL COST FOR ONCOS-102 PHASE 2 STUDY, INCLUDING
ASSOCIATED MANUFACTURING AND SUPPLY, IS ESTIMATED AT UP TO NOK
400M
    * STRONGLY BELIEVE IN POTENTIAL OF ONCOS-102, AND WE ARE
LOOKING
AT STRATEGIC OPTIONS TO ENABLE CONTINUED CLINICAL DEVELOPMENT
    * TG01 MUTANT RAS CANCER VACCINE PROGRAM WILL BE UNAFFECTED
    * BOARD STRONGLY RECOMMENDS ALL SHAREHOLDERS TO SUPPORT
PROPOSED
NOK 300M CONVERTIBLE BOND FACILITY

Source text for Eikon:  ID:nWkr46Ypzh 
Further company coverage:  TRVX.OL 

 ((Reuters.Briefs@thomsonreuters.com;))